Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
Barchart on MSN2d
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?
With a market cap of $118.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology leader specializing ...
CRN1y
Cohesity, Google Cloud Team Up For Vertex AI Data Protection
Cohesity is teaming with Google to apply Google’s generative AI platform Vertex AI to solve the complexity ... stores across on-premises, cloud, and edge environments. Sanjay Poonen Data ...
Benzinga.com19d
Vertex Pharmaceuticals Unusual Options Activity
Vertex Pharmaceuticals is a global biotechnology ... Next earnings are expected to be released in 7 days. Benzinga Edge's Unusual Options board spots potential market movers before they happen.